Spontaneous Hematological Remission Of Acute Myeloid Leukemia
Kaźmierczak, M., Szczepaniak, A., Czyż, A., Rupa-Matysek, J., & Komarnicki, M. (2014). spontaneous hematological remission of acute myeloid leukemia. Contemporary oncology (Poznan, Poland), 18(1), 67–69. https://doi.org/10.5114/wo.2013.38915
View Original Source →Abstract
Spontaneous remission (SR) of acute myeloid leukemia (AML) in adults is observed very rarely. To date, about 100 cases have been presented in the literature. To our best knowledge, we describe the first adult Polish patient suffering from acute myelomonocytic leukemia (48, XY, +13, +21/46, XY), in whom after supportive therapy, including non-irradiated, non-leukocyte depleted red cell transfusions and low-dose corticosteroid, we observed resolution of the disease without cytogenetic remission. We suggest a potential transfusion-associated graft versus-host-diseases (TA-GVHD) and graft-versus leukemia (GVL) reaction which might lead to spontaneous hematological remission. However, we did not observe clinical symptoms of such reactions apart from a short episode of non-infectious diarrhea. Additionally, steroids were administered but their role in inducing SR, in our opinion, seems less probable. This 77-year-old man remained in SR for 7 months, when repeated analysis showed AML recurrence. He died due to septic shock 2.5 months later. Additionally, we present a review of the literature.
Case Details
Disease Location
Blood
Personal Characteristics
77-year-old man
Clinical Characteristics
Suffering from fatigue, dizziness and mild weight loss, which started in august, 2011. Laboratory tests showed anemia (hb 3.7 mmol/l), leukopenia with granulocytopenia (wbc 2.3 g/l, granulocyte count 0.26 g/l), and moderately elevated lactate dehydrogenase. Based on cytomorphology, cytochemistry and also on immunophenotyping, the diagnosis of acute myelomonocytic leukemia was established.
Remission Characteristics
By november 2011, the complete blood count became normal, with hb 7.8 mmol/l, wbc 4.54 g/l, and platelet count of 165.0 g/l. Repeated cytologic and immunocytometric evaluation of pb and bm showed complete hematological remission
Treatment & Mechanisms
Proposed Remission Mechanisms
Transfusion-associated graft versus-host-diseases and graft-versus leukemia
Clinical Treatment
Non-irradiated red cell transfusions (4 units) and low-dose methylprednisolone